IEET > Directors > Fellows > Aubrey de Grey > HealthLongevity > Nick Bostrom > J. Hughes
Securing the Longevity Dividend: Building the Campaign for Anti-Aging Science
Jul 23, 2007  

Monday, July 23, 2007 - Chicago, Illinois

Chicago Fairmont Hotel (same hotel as Transvision 2007 which will take place the following three days)

Faculty: Jay Olshansky Ph.D., U of IL-C; David Meltzer M.D., Ph.D., U. of Chicago; Aubrey de Grey Ph.D., Methuselah Foundation; Nick Bostrom Ph.D., Oxford U.; Anders Sandberg Ph.D., Oxford U.; James J. Hughes Ph.D., IEET; Ronald Bailey, Reason magazine; George Dvorsky, IEET

Speakers - Agenda  - Registration - Resources - Intended Audience


“Securing the Longevity Dividend” (PPT)

Stuart Jay Olshansky Ph.D. Professor of Epidemiology University of Chicago As chief author of The Quest For Immortality: Science At The Frontiers Of Ageing, Professor Stuart Jay Olshansky is a leading proponent of the study of the challenges and opportunities presented by increased human longevity. He has made several contributions to the scientific movement to extend and improve later life, and helped to introduce the concept of the Longevity Dividend - the sum of health, social and economic benefits that result from slower ageing. With a first degree in psychology from Michigan State University, he was awarded his master’s and doctorate in sociology by the University of Chicago in 1982-84. His publications as author, co-author or editor comprise 17 articles and two books. They include A potential decline in life expectancy in the United States in the 21st century for the New England Journal of Medicine; In Search of Methuselah: Estimating the Upper Limits to Human Longevity for Science; and In pursuit of the Longevity Dividend for The Scientist. Recent honours include a Fulbright fellowship in 2005.

“Taxes on the Longevity Dividend: Is there a price to ignoring them?” (PPT)

David O. Meltzer, M.D., Ph.D. is an Associate Professor, Department of Medicine, the Economics Department, and the Harris School of Public Policy at the University of Chicago. Meltzer’s research explores problems in health economics and public policy. His recent work has focused on the theoretical foundations of medical cost-effectiveness analysis, including issues such as accounting for future costs due to the extension of life and the empirical validity of quality of life assessment, which he has examined in the context of diabetes and prostate cancer. He is also a faculty research fellow for the National Bureau of Economic Research and has served on a panel that examined the “Future of Medicare” for the National Academy of Social Insurance.

“Arguing the Scientific Feasibility of Anti-Aging” (PPT)

Aubrey de Grey Ph.D. is a biogerontologist, creator of the Methuselah Mouse prize, and Chairman and Chief Science Officer of the Methuselah Foundation. He designs interventions to reverse the cellular and molecular changes that accumulate with age and reduce remaining life expectancy. He has coined the term “strategies for engineered negligible senescence” (SENS) to describe these interventions, which he argues are the only feasible way to extend human lifespan by more than a decade.  He has published widely on SENS.  Aubrey is the co-founder and chief scientist of the Methuselah Mouse Prize, a contest designed to accelerate research into effective life extension interventions by awarding prizes to researchers who extend the lifespan of mice to unprecedented lengths. Aubrey serves as editor-in-chief of Rejuvenation Research.

“Building Coalitions for Anti-Aging Science and Medicine”

James Hughes Ph.D., the IEET Executive Director, is a bioethicist and sociologist at Trinity College in Hartford Connecticut where he teaches Health Policy. He holds a doctorate in sociology from the University of Chicago, where he also taught bioethics. Dr. Hughes is author of Citizen Cyborg: Why Democratic Societies Must Respond to the Redesigned Human of the Future (Westview Press, 2004), and produces a syndicated weekly radio program, Changesurfer Radio. He is a Fellow of the World Academy of Arts and Sciences, and a member of the American Society of Bioethics and Humanities and the Working Group on Ethics and Technology at Yale University. Dr. Hughes speaks on medical ethics, health care policy and future studies worldwide, and appears often radio and television.

“The Political Economy of the Longevity Dividend” (PPT)

Ron Bailey is the science correspondent for Reason, the monthly national magazine on politics and culture. His new book, Liberation Biology: The Scientific And Moral Case For The Biotech Revolution, is a positive, optimistic, and convincing argument that the biotechnology revolution will improve our lives and the future of our children. Ron has been reporting on biotechnology over the past 15 years for the Wall Street Journal, Los Angeles Times, The Public Interest, Commentary, the Philadelphia Inquirer and other publications. He has also been a staff writer for Forbes magazine covering economic, scientific and business topics, and his articles and reviews have appeared in The Wall Street Journal, The Washington Post, Commentary, The New York Times Book Review, The Public Interest, Smithsonian, National Review, Forbes, The Washington Times, Newsday, and Readers Digest.  Ron speaks frequently on biotechnology topics. He recently debated Francis Fukuyama, author of Our Posthuman Future, at the American Association for the Advancement of Science on the ethics of significantly extending human lifespans. He has lectured at Harvard University, Yale University, Morehouse University, the Massachusetts Institute of Technology, the Medical University of South Carolina, the New America Foundation, Rutgers University, American University, the University of Virginia, McGill University, University of Alaska, Universite de Quebec, the Cato Institute, the Instituto de Libertad y Desarrollo (Chile), the Foundation for the Future, and the American Enterprise Institute.

“Policy Scenarios for the Longevity Dividend” (PPT)

Anders Sandberg a Swedish neuroscientist and futurist. He holds a Ph.D. in computational neuroscience from Stockholm University and has studied computer models of human memory at the Royal Institute of Technology, Stockholm, Sweden. He has also been scientific producer for the neuroscience exhibition “Se Hjärnan!” (“Behold the Brain!”), organized by Swedish Travelling Exhibitions, the Swedish Research Council and the Knowledge Foundation that is touring Sweden 2005-2006.  He is co-founder of and writer for the think tank Eudoxa. Between 1996 and 2000 he was Chairman of the Swedish Transhumanist Association.His other interests include physics, astronomy, biomedicine, psychology, complexity theory, art, sciencefiction, roleplaying, computer graphics, artificial intelligence, cognitive science, information visualization, intelligence amplification technologies, and the philosophy and politics of human enhancement. Anders is the Postdoctoral Research Assistant for the Oxford ENHANCE Project. the Enhance Project is hosted by the Uehiro Centre for Practical Ethics.

“Popular Arguments For and Against Longevity” (PPT)

George Dvorsky is the Deputy-Editor of Betterhumans, co-founder and president of the Toronto Transhumanist Association, and the producer of the award-winning Sentient Developments blog and podcast. Mr. Dvorsky served as conference chair for TransVision 2004, the WTA’s annual conference, and is the co-director of the IEET Cyborg Buddha project. Mr. Dvorsky speaks often with print and broadcast media about bioethics, on topics ranging from disability rights to sport enhancement.


8:30am-9am Registration & coffee

9am-Noon Politics and Economics of the Longevity Dividend
Jay Olshansky Ph.D.
Anders Sandberg Ph.D.
David Meltzer M.D., Ph.D.
Ron Bailey

Noon-1:30pm Lunch

1:30-5pm Building the Campaign for the Longevity Dividend
Aubrey de Grey Ph.D.
James Hughes Ph.D.
George Dvorsky

Intended Audience:

The targets for this event are:

- scholars and journalists interested in the future of aging and healtcare
- legislative aides and policy makers considering Longevity Dividend as a policy program
- pro-longevity, health care and senior activists interested in building the Longevity Dividend campaign